Study guide

16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases

Australian Dental Council ADC

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Examination Overview

1.1 ADC Written Examination Structure, Scoring Clusters & Australian Practice Context 1.2 Clinical Scenario Reasoning & Australian Therapeutic Guidelines Alignment

2 Chapter 2: Restorative Dentistry & Fixed Prosthodontics

2.1 Minimal Intervention Dentistry, Caries Risk & Lesion Management 2.2 Direct Restorative Materials, Resin Composites & Dental Amalgam 2.3 Indirect Restorations, Crown Preparation, Veneers & Onlays 2.4 Dental Adhesion, Etch-and-Rinse vs Self-Etch Systems & Hybrid Layer 2.5 Diagnosis & Management of Tooth Wear (Erosion, Attrition, Abrasion, Abfraction)

3 Chapter 3: Dental Pharmacology & Therapeutic Guidelines

3.1 Local Anaesthetic Agents, Vasoconstrictors & Injection Techniques 3.2 Dental Analgesia Protocols, NSAIDs, Paracetamol & Opioid Stewardship 3.3 Dental Antibiotic Prescribing, Prophylaxis & Therapeutic Guidelines 3.4 Management of Patients on Anticoagulants & Antiplatelet Therapy 3.5 Medication-Related Osteonecrosis of the Jaw (MRONJ) Risk & Management

4 Chapter 4: General Medicine & Medically Compromised Patients

4.1 Dental Office Medical Emergencies, Anaphylaxis & Resuscitation Protocols 4.2 Management of Patients with Cardiovascular, Respiratory & Renal Diseases 4.3 Special Needs Dentistry, Geriatric Care & Dental Management in Pregnancy 4.4 Infective Endocarditis Prophylaxis & Cardiac Risk Assessment

5 Chapter 5: Oral Medicine & Oral Pathology

5.1 Ulcerative, Vesiculobullous & Immune-Mediated Oral Mucosal Diseases 5.2 Oral Potentially Malignant Disorders (OPMDs) & Oral Cancer Screening 5.3 Salivary Gland Disorders, Sialadenitis & Cysts of the Jaws 5.4 Oral Biopsy Indications, Diagnostic Pathways & Specialist Referral

6 Chapter 6: Endodontics

6.1 Pulpal and Periapical Diagnostic Classification & Diagnostic Testing 6.2 Canal Instrumentation, Working Length & Irrigation Protocols 6.3 Root Canal Obturation, Endodontic Retreatment & Failure Analysis 6.4 Endodontic Management of Traumatic Dental Injuries & Vital Pulp Therapy

7 Chapter 7: Oral Surgery

7.1 Surgical & Simple Exodontia Techniques & Intraoperative Complications 7.2 Assessment & Surgical Management of Impacted Third Molars 7.3 Oroantral Communication, Displacement & Trigeminal Nerve Injury Prevention 7.4 Management of Spreading Odontogenic Infections & Fascial Space Abscesses

8 Chapter 8: Paediatric Dentistry & Orthodontics

8.1 Primary Tooth Pulpotomy, Pulpectomy & Stainless Steel Crown Restoration 8.2 Early Childhood Caries, Space Maintenance & Traumatic Primary Dentition 8.3 Malocclusion Classification, Etiology & Interceptive Orthodontic Management 8.4 Non-Pharmacological Behaviour Guidance, Child Protection & Consent

9 Chapter 9: Periodontics

9.1 2018 Periodontal Staging, Grading & Risk Factor Assessment 9.2 Subgingival Debridement, Plaque Control & Antimicrobial Adjuncts 9.3 Periodontal Surgical Flaps, Regenerative Therapy & Furcation Management 9.4 Supportive Periodontal Care, Maintenance Protocols & Risk Re-evaluation

10 Chapter 10: Preventive Dentistry

10.1 Caries Risk Assessment Models (CAMBRA) & Personalised Prevention 10.2 Fluoride Mechanisms, Topical Applications & Community Fluoridation 10.3 Dietary Counselling, Stephan Curve Dynamics & Erosion Prevention 10.4 Pit and Fissure Sealants, Casein Phosphopeptide-Amorphous Calcium Phosphate (CPP-ACP)

11 Chapter 11: Dental Emergencies

11.1 Emergency Management of Severe Odontogenic Pain & Acute Irreversible Pulpitis 11.2 Acute Management of Avulsed, Luxated & Fractured Permanent Teeth 11.3 Diagnosis, Differentiation & Treatment of Cracked Tooth Syndrome 11.4 Emergency Management of Post-Extraction Hemorrhage & Acute Abscesses

12 Chapter 12: Pain & Behaviour Management

12.1 Assessment & Management of Dental Anxiety, Phobia & Dental Fear 12.2 Nitrous Oxide Inhalation Sedation & Intravenous Sedation Guidelines 12.3 Diagnosis & Management of Temporomandibular Disorders & Chronic Facial Pain 12.4 Informed Consent, Patient Autonomy, Ethics & Professional Boundaries

13 Chapter 13: Removable Prosthodontics

13.1 Complete Denture Design, Impression Techniques & Maxillomandibular Relations 13.2 Removable Partial Denture Design, Surveying, Clasping & RPI System 13.3 Post-Insertion Problems, Sore Spots, Relining & Rebase Procedures 13.4 Denture Stomatitis, Tissue Conditioning & Pre-Prosthetic Surgery

14 Chapter 14: Dental Radiography & Imaging

14.1 Radiation Physics, ALARA Principles, Shielding & Dose Reduction 14.2 Intraoral Radiographic Techniques, Positioning & Geometry 14.3 Radiographic Interpretation, Normal Anatomical Landmarks & Artifacts

15 Chapter 15: Infection Prevention & Control

15.1 Standard & Transmission-Based Precautions in Dental Practice 15.2 Instrument Reprocessing, Autoclaving & Sterilisation Monitoring 15.3 Dental Unit Waterlines, Waste Management & Occupational Exposure Protocols

16 Chapter 16: Dental Implants & Peri-Implant Diseases

16.1 Patient Selection, Bone Density, Anatomic Constraints & Prosthetic Planning 16.2 Peri-Implant Anatomy, Hygiene Protocols & Maintenance Monitoring 16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases

16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases

Key Takeaways Explain This Topic AI

Under the 2017 AAP/EFP World Workshop Classification, Peri-Implant Mucositis is defined as plaque-induced soft tissue inflammation (BOP/suppuration) without bone loss beyond initial remodeling, whereas Peri-Implantitis involves mucosal inflammation combined with progressive crestal bone loss.

Diagnostic criteria for Peri-Implantitis in the absence of baseline data require Bleeding on Probing (BOP) and/or suppuration, probing depths ≥6.0 mm, and crestal bone levels ≥3.0 mm apical to the intra-mucosal portion of the implant.

Major modifiable and non-modifiable risk factors include a history of severe periodontitis (odds ratio 2–5x), tobacco smoking, uncontrolled diabetes, lack of keratinized mucosa (<2.0 mm), and subgingival entrapment of residual restorative cement.

Peri-Implant Mucositis is fully reversible with non-surgical mechanical debridement, glycine/erythritol air-polishing, and chemical plaque control; conversely, non-surgical therapy alone shows low predictability in resolving Peri-Implantitis.

Surgical management of Peri-Implantitis incorporates open flap debridement, implant surface decontamination (titanium brushes, citric acid, air-polishing), and either resective surgery with implantoplasty or regenerative Guided Bone Regeneration (GBR), guided by the Cumulative Interceptive Supportive Therapy (CIST) protocol.

Last updated: August 2026

16.3 Diagnosis, Risk Factors & Management of Peri-Implant Diseases

Peri-implant diseases represent plaque-associated inflammatory conditions occurring in the tissues surrounding dental implants. Defined globally by the 2017 AAP/EFP World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions and endorsed by the Australian Society of Periodontology (ASP) and Dental Board of Australia (DBA) , peri-implant conditions range from reversible soft tissue inflammation to progressive, destructive bone loss. For candidates taking the ADC Written Examination , a thorough understanding of the diagnostic definitions, risk factor profiles, non-surgical interceptive protocols, surgical decontamination techniques, and explantation criteria is essential.

1. 2017 AAP/EFP Classification & Diagnostic Criteria

The 2017 World Workshop established standardized, evidence-based diagnostic criteria distinguishing peri-implant health, peri-implant mucositis, and peri-implantitis.

Classification Visual Inflammation Bleeding on Probing (BOP) / Suppuration Probing Depth (PD) Radiographic Crestal Bone Levels

Peri-Implant Health Absence of erythema, edema, or swelling. Absence of BOP and suppuration. Stable baseline PDs (typically ≤3–4 mm). Absence of bone loss beyond physiological remodeling (≤1.5–2.0 mm post-loading).

Peri-Implant Mucositis Presence of erythema, edema, and mucosal swelling. Presence of BOP and/or suppuration. Increased PD compared to baseline due to swelling. Absence of progressive bone loss beyond initial physiological remodeling.

Peri-Implantitis Visual mucosal inflammation and swelling. Presence of BOP and/or suppuration upon probing. Increased PD (typically ≥6.0 mm) compared to baseline. Progressive crestal bone loss extending beyond physiological remodeling.

Diagnostic Cutoffs when Baseline Radiographs / Probing Depths are ABSENT:

When previous clinical records or baseline radiographs are unavailable, the 2017 AAP/EFP classification mandates diagnosing Peri-Implantitis based on the following triad:

Presence of Bleeding on Probing (BOP) and/or suppuration.

Probing Depths ≥6.0 mm .

Radiographic bone levels ≥3.0 mm apical to the most coronal portion of the intra-mucosal part of the implant.

2. Etiology & Risk Factors / Indicators

Peri-implantitis is an infectious disease driven by polymicrobial biofilm dysbiosis, characterized by a shift toward anaerobic Gram-negative periodontopathogens ( Porphyromonas gingivalis , Tannerella forsythia , Treponema denticola , Fusobacterium nucleatum ). Several local and systemic risk factors significantly increase patient susceptibility. +-----------------------------------------------------------------------------------------+

  • | RISK FACTORS & INDICATORS FOR PERI-IMPLANTITIS |
  • +-----------------------------------------------------------------------------------------+
  • | Patient-Related | History of severe periodontitis (OR 2-5x), Smoking, Uncontrolled Diabetes |
  • | Local / Tissue | Lack of Keratinized Mucosa (<2.0 mm), Poor oral hygiene / compliance |
  • | Iatrogenic | Subgingival RESIDUAL CEMENT entrapment, Implant malposition |
  • +-----------------------------------------------------------------------------------------+

History of Periodontitis: The strongest patient-level risk factor. Untreated or poorly managed periodontitis provides a reservoir of pathogenic bacteria that cross-colonize peri-implant sites.

Subgingival Excess Restorative Cement (Iatrogenic): Retained subgingival cement following cementation of implant crowns creates a rough, porous substrate for heavy bacterial colonization. This frequently triggers acute, rapid suppurative breakdown and severe localized bone loss.

Lack of Keratinized Mucosa (<2.0 mm): A band of keratinized tissue <2.0 mm around transmucosal abutments increases patient discomfort during brushing, plaque accumulation, mucosal recession, and tissue inflammation.

Implant Malposition & Uncleanable Prosthetic Contours: Implants placed too close together (<3.0 mm) or crowns featuring concave, non-cleansable emergence profiles prevent effective mechanical plaque control by the patient.

3. Non-Surgical Management Protocols

Non-surgical therapy is the mandatory first-line treatment for peri-implant mucositis and serves as the initial phase of peri-implantitis control.

A. Peri-Implant Mucositis Treatment (Fully Reversible)

Mechanical Debridement: Complete removal of biofilm and calculus using pure titanium scalers, carbon-fiber curettes, or subgingival glycine/erythritol air-polishing .

Removal of Iatrogenic Triggers: Elimination of overhanging crown margins and complete removal of subgingival residual cement.

Antiseptic Rinses: 0.12% Chlorhexidine gluconate mouthrinse twice daily for 2 to 3 weeks.

Prosthetic Modification: Recontouring crown contours if they impede interdental brushing.

Prognosis: High predictability; full resolution of inflammation and return to health.

B. Non-Surgical Treatment of Peri-Implantitis (Limited Predictability)

While non-surgical debridement reduces soft tissue inflammation, it rarely achieves complete disease resolution or re-osseointegration in deeper peri-implantitis pockets (≥6.0 mm).

Adjunctive Antimicrobials: Controlled-release local antimicrobials (e.g., Minocycline microspheres or Doxycycline hyclate gel) placed into deep pockets provide modest short-term probing depth reductions.

Systemic Antibiotics: Routine systemic antibiotics during non-surgical therapy are not recommended due to limited efficacy and antimicrobial resistance concerns.

4. Surgical Interventions for Peri-Implantitis

When non-surgical therapy fails to eliminate deep pockets (≥6.0 mm), suppuration, and active BOP after 6 to 12 weeks, surgical intervention is indicated. +-----------------------------------------------------------------------------------------+

  • | SURGICAL MANAGEMENT OF PERI-IMPLANTITIS |
  • +-----------------------------------------------------------------------------------------+
  • | Step 1: Open Flap Debridement (OFD) | Full-thickness mucoperiosteal flap reflection |
  • | Step 2: Surface Decontamination | Titanium brushes, Citric acid 24%, Air-polishing |
  • | Step 3A: Resective + Implantoplasty | Smoothing exposed threads (Non-esthetic zones) |
  • | Step 3B: Regenerative (GBR) | Bone graft + Barrier membrane (3-wall defects) |
  • +-----------------------------------------------------------------------------------------+
  • A. Step 1: Flap Reflection & Granulation Tissue Removal

Full-thickness mucoperiosteal flaps are reflected buccally and lingually under local anesthesia.

Inflammatory granulation tissue filling the intra-bony defect is completely curetted using titanium scalers.

B. Step 2: Implant Surface Decontamination (Critical Phase)

Decontamination of the contaminated, micro-rough titanium surface is necessary to render the surface biocompatible.

Mechanical Decontamination: Rotary titanium brushes , subgingival glycine/erythritol air-polishing, or Er:YAG laser ablation.

Chemical Decontamination: Application of 24% Citric Acid for 1 minute, 3% Hydrogen Peroxide, or Chlorhexidine 0.2% gel, followed by copious sterile saline irrigation.

C. Step 3: Selection of Surgical Modality

Resective Surgery & Implantoplasty:

Indications: Suprabony defects, 1-wall or 2-wall shallow bone defects, and non-esthetic areas (posterior mandible).

Procedure: Apical positioning of the soft tissue flap combined with Implantoplasty —using diamond and carbide burs to smooth away the rough exposed titanium threads, leaving a polished surface that inhibits re-colonization by bacterial biofilm.

Regenerative Surgery (Guided Bone Regeneration - GBR):

Indications: Self-containing, deep intra-bony defects (3-wall or circumferential defects) in esthetic zones.

Procedure: Filling the decontaminated defect with particulate bone graft (autogenous bone combined with xenograft/bovine bone mineral) and covering with a resorbable collagen barrier membrane to achieve re-osseointegration.

5. Cumulative Interceptive Supportive Therapy (CIST) & Explantation

The CIST Protocol offers a structured, step-wise clinical treatment matrix based on probing depth, bleeding, and bone loss severity.

CIST Stage Clinical Findings Required Interceptive Treatment

Stage A Probing Depth 3–4 mm, Bleeding on Probing (+) Mechanical Debridement: Oral hygiene instruction, polishing, air-polishing.

Stage B Probing Depth 4–5 mm, Bleeding on Probing (+) Antiseptic Therapy: Stage A + Chlorhexidine 0.12% irrigation/rinse for 3 weeks.

Stage C Probing Depth >5 mm, BOP (+), Bone Loss 2–4 mm Antimicrobial Therapy: Stage A + B + Local controlled-release antibiotics.

Stage D Probing Depth >5 mm, BOP (+), Bone Loss >4 mm Surgical Therapy: Stage A + B + C + Open flap debridement, surface decontamination, and Resective/Regenerative surgery.

Indications for Implant Explantation (Removal)

Implant retention is not always viable. Explantation is mandatory under the following conditions:

Clinical Fixture Mobility: Pathognomonic for total loss of osseointegration.

Extreme Bone Loss (>50% to 70% of implant length): Accompanied by refractory suppuration despite surgical intervention.

Severe Implant Malposition: Renders the implant unrestorable or un-cleansable.

Technique: Explantation should utilize reverse-torque extraction kits or ultra-thin trephine burs to preserve host bone for future site reconstruction.

Loading diagram... Diagnostic and Therapeutic Algorithm for Peri-Implant Diseases (2017 EFP/AAP Framework)